We updated the design of this site on December 18, 2017. Learn more.
ClinicalTrials.gov Menu

Influence of Trimethoprim-Sulfamethoxazole for the Recurrence of Ocular Toxoplasmosis (ISROT)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT01449877
Recruitment Status : Completed
First Posted : October 10, 2011
Last Update Posted : July 12, 2016
Fundação de Amparo à Pesquisa do Estado de São Paulo
Information provided by (Responsible Party):
Joao Paulo Felix, University of Campinas, Brazil